These are the highlights New markets in Australia including hospitals, GP, home care operators and direct to home family members for the remainder of 2019. 100,000 residents for new government grant . UK, Singapore and New Zealand and target to have commercial agreements in place in each market by the end of June 2019 Scheduling a face to face meeting with FDA in the USA prior to June 30th 2019 The PainChek children’s App version is close to starting clinical trials in a leading Australian children’s hospital and serves an even larger market, where globally there are more than 400 million children between the aged of 0-3 years. The Company is on target to achieve its commercial milestones for calendar 2019 and become the new global gold standard for pain assessment in multiple healthcare market segments.
PCK Price at posting:
3.4¢ Sentiment: None Disclosure: Held
